Abstract
The concentration range of GTN causing inhibition of platelet aggregation in vitro is much higher than the plasma concentrations achieved clinically. This action is potentiated by the sulphydryl donor N-acetylcysteine. We have investigated the effects of GTN given with and without N-acetylcysteine on ex vivo platelet aggregation in man. In a double-blind randomised crossover trial eight healthy volunteers were treated with 20 mg of transdermal GTN/24 h, together with N-acetylcysteine 200 mg three times daily or matching placebo. Platelet aggregation, measured ex vivo by whole blood impedance aggregometry in response to adenosine diphosphate, was not significantly altered by GTN acutely or after 4 days' treatment with or without N-acetylcysteine. Platelet cyclic guanosine monophosphate levels were not significantly altered by GTN either in the absence or presence of N-acetylcysteine. This result implies that previously reported beneficial effects of GTN in myocardial infarction or unstable angina are unlikely to be attributable to direct pharmacological inhibition of platelet aggregation.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hampton J. R., Harrison M. J., Honour A. J., Mitchell J. R. Platelet behaviour and drugs used in cardiovascular disease. Cardiovasc Res. 1967 Apr;1(2):101–107. doi: 10.1093/cvr/1.2.101. [DOI] [PubMed] [Google Scholar]
- Hogan J. C., Lewis M. J., Henderson A. H. In vivo EDRF activity influences platelet function. Br J Pharmacol. 1988 Aug;94(4):1020–1022. doi: 10.1111/j.1476-5381.1988.tb11616.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Horowitz J. D., Antman E. M., Lorell B. H., Barry W. H., Smith T. W. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation. 1983 Dec;68(6):1247–1253. doi: 10.1161/01.cir.68.6.1247. [DOI] [PubMed] [Google Scholar]
- Horowitz J. D., Henry C. A., Syrjanen M. L., Louis W. J., Fish R. D., Smith T. W., Antman E. M. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. Circulation. 1988 Apr;77(4):787–794. doi: 10.1161/01.cir.77.4.787. [DOI] [PubMed] [Google Scholar]
- Ignarro L. J., Lippton H., Edwards J. C., Baricos W. H., Hyman A. L., Kadowitz P. J., Gruetter C. A. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981 Sep;218(3):739–749. [PubMed] [Google Scholar]
- Loscalzo J. N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest. 1985 Aug;76(2):703–708. doi: 10.1172/JCI112024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mehta J., Mehta P. Comparative effects of nitroprusside and nitroglycerin on platelet aggregation in patients with heart failure. J Cardiovasc Pharmacol. 1980 Jan-Feb;2(1):25–33. doi: 10.1097/00005344-198001000-00004. [DOI] [PubMed] [Google Scholar]
- Needleman P. Organic nitrate metabolism. Annu Rev Pharmacol Toxicol. 1976;16:81–93. doi: 10.1146/annurev.pa.16.040176.000501. [DOI] [PubMed] [Google Scholar]
- Sioufi A., Pommier F. Quantitative determination of nitroglycerin in human plasma by capillary gas chromatography with electron-capture detection. J Chromatogr. 1985 Apr 12;339(1):117–126. doi: 10.1016/s0378-4347(00)84633-2. [DOI] [PubMed] [Google Scholar]
- Winniford M. D., Kennedy P. L., Wells P. J., Hillis L. D. Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine. Circulation. 1986 Jan;73(1):138–142. doi: 10.1161/01.cir.73.1.138. [DOI] [PubMed] [Google Scholar]
- Yusuf S., Collins R., MacMahon S., Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet. 1988 May 14;1(8594):1088–1092. doi: 10.1016/s0140-6736(88)91906-x. [DOI] [PubMed] [Google Scholar]